SF3A1 and cancer: Our functional assay showed that SF3A1 strongly promoted the cell growth in cancer cells (HCT116, SUIT-2, OE33 and KYSE-70 cells) specifically, indicating that SF3A1 is a viable therapeutic target for tumor therapy.